News Roundup [abridged Versions Appear In The Paper Journal]

Nine drug company chiefs are charged with conspiracy to defraud NHS

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7546.872-c (Published 13 April 2006) Cite this as: BMJ 2006;332:872
  1. Owen Dyer
  1. London

    Nine British pharmaceutical executives have been charged with conspiracy to defraud the NHS, after an investigation by the Serious Fraud Office into price fixing of generic drugs.

    Five companies have also been charged with colluding to keep prices high: Goldshield Group, Kent Pharmaceuticals, Norton Healthcare, Generics (UK), and Ranbaxy (UK). All the companies and individuals charged deny wrongdoing.

    The Serious Fraud Office's inquiry, dubbed Operation Holbein, is one of its biggest ever cases, involving up to 150 investigators. Officers raided six companies in 2002. One, Regent-GM Laboratories, has since been wound up. The other five are those charged last week. …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe